An eMERGE Clinical Center at Partners Personalized Medicine
- PMID:26805891
- PMCID: PMC4810384
- DOI: 10.3390/jpm6010005
An eMERGE Clinical Center at Partners Personalized Medicine
Abstract
The integration of electronic medical records (EMRs) and genomic research has become a major component of efforts to advance personalized and precision medicine. The Electronic Medical Records and Genomics (eMERGE) network, initiated in 2007, is an NIH-funded consortium devoted to genomic discovery and implementation research by leveraging biorepositories linked to EMRs. In its most recent phase, eMERGE III, the network is focused on facilitating implementation of genomic medicine by detecting and disclosing rare pathogenic variants in clinically relevant genes. Partners Personalized Medicine (PPM) is a center dedicated to translating personalized medicine into clinical practice within Partners HealthCare. One component of the PPM is the Partners Healthcare Biobank, a biorepository comprising broadly consented DNA samples linked to the Partners longitudinal EMR. In 2015, PPM joined the eMERGE Phase III network. Here we describe the elements of the eMERGE clinical center at PPM, including plans for genomic discovery using EMR phenotypes, evaluation of rare variant penetrance and pleiotropy, and a novel randomized trial of the impact of returning genetic results to patients and clinicians.
Keywords: Partners Biobank; Partners Personalized Medicine; biorepository; eMERGE; electronic medical records; genomics; personalized medicine; precision medicine.
Figures
Similar articles
- The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies.McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, Larson EB, Li R, Masys DR, Ritchie MD, Roden DM, Struewing JP, Wolf WA; eMERGE Team.McCarty CA, et al.BMC Med Genomics. 2011 Jan 26;4:13. doi: 10.1186/1755-8794-4-13.BMC Med Genomics. 2011.PMID:21269473Free PMC article.
- Infrastructure for Personalized Medicine at Partners HealthCare.Weiss ST, Shin MS.Weiss ST, et al.J Pers Med. 2016 Feb 27;6(1):13. doi: 10.3390/jpm6010013.J Pers Med. 2016.PMID:26927187Free PMC article.
- Return of results in the genomic medicine projects of the eMERGE network.Kullo IJ, Haddad R, Prows CA, Holm I, Sanderson SC, Garrison NA, Sharp RR, Smith ME, Kuivaniemi H, Bottinger EP, Connolly JJ, Keating BJ, McCarty CA, Williams MS, Jarvik GP.Kullo IJ, et al.Front Genet. 2014 Mar 26;5:50. doi: 10.3389/fgene.2014.00050. eCollection 2014.Front Genet. 2014.PMID:24723935Free PMC article.
- The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future.Gottesman O, Kuivaniemi H, Tromp G, Faucett WA, Li R, Manolio TA, Sanderson SC, Kannry J, Zinberg R, Basford MA, Brilliant M, Carey DJ, Chisholm RL, Chute CG, Connolly JJ, Crosslin D, Denny JC, Gallego CJ, Haines JL, Hakonarson H, Harley J, Jarvik GP, Kohane I, Kullo IJ, Larson EB, McCarty C, Ritchie MD, Roden DM, Smith ME, Böttinger EP, Williams MS; eMERGE Network.Gottesman O, et al.Genet Med. 2013 Oct;15(10):761-71. doi: 10.1038/gim.2013.72. Epub 2013 Jun 6.Genet Med. 2013.PMID:23743551Free PMC article.Review.
- Biorepositories and Databanks for the Development of Novel Biomarkers for Genitourinary Cancer Prevention and Management.Wagner H, Kenk M, Fraser M, Berlin A, Fleshner N.Wagner H, et al.Eur Urol Focus. 2021 May;7(3):513-521. doi: 10.1016/j.euf.2021.06.002. Epub 2021 Jun 22.Eur Urol Focus. 2021.PMID:34167926Review.
Cited by
- Implementing Personalized Medicine in the Academic Health Center.Weiss ST.Weiss ST.J Pers Med. 2016 Sep 21;6(3):18. doi: 10.3390/jpm6030018.J Pers Med. 2016.PMID:27657137Free PMC article.
- TET2-mutant clonal hematopoiesis and risk of gout.Agrawal M, Niroula A, Cunin P, McConkey M, Shkolnik V, Kim PG, Wong WJ, Weeks LD, Lin AE, Miller PG, Gibson CJ, Sekar A, Schaefer IM, Neuberg D, Stone RM, Bick AG, Uddin MM, Griffin GK, Jaiswal S, Natarajan P, Nigrovic PA, Rao DA, Ebert BL.Agrawal M, et al.Blood. 2022 Sep 8;140(10):1094-1103. doi: 10.1182/blood.2022015384.Blood. 2022.PMID:35714308Free PMC article.
- Genome-wide discovery for diabetes-dependent triglycerides-associated loci.Selvaraj MS, Paruchuri K, Haidermota S, Bernardo R, Rich SS, Peloso GM, Natarajan P.Selvaraj MS, et al.PLoS One. 2022 Oct 21;17(10):e0275934. doi: 10.1371/journal.pone.0275934. eCollection 2022.PLoS One. 2022.PMID:36269708Free PMC article.
- Genetic Loci and Physiologic Pathways Involved in Gestational Diabetes Mellitus Implicated Through Clustering.Powe CE, Udler MS, Hsu S, Allard C, Kuang A, Manning AK, Perron P, Bouchard L, Lowe WL Jr, Scholtens D, Florez JC, Hivert MF.Powe CE, et al.Diabetes. 2021 Jan;70(1):268-281. doi: 10.2337/db20-0772. Epub 2020 Oct 13.Diabetes. 2021.PMID:33051273Free PMC article.
- High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease.Kim H, Westerman KE, Smith K, Chiou J, Cole JB, Majarian T, von Grotthuss M, Kwak SH, Kim J, Mercader JM, Florez JC, Gaulton K, Manning AK, Udler MS.Kim H, et al.Diabetologia. 2023 Mar;66(3):495-507. doi: 10.1007/s00125-022-05848-6. Epub 2022 Dec 20.Diabetologia. 2023.PMID:36538063Free PMC article.
References
- Aronson S., Mahanta L., Ros L.L., Clark E., Babb L., Oates M., Rehm H., Lebo M. Information technology support for clinical genetic testing within an academic medical center. Partners HealthCare Personalized Medicine, Cambridge, MA, USA. J. Pers. Med. 2016 doi: 10.3390/jpm6010004. - DOI - PMC - PubMed
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources